Clinical Cancer Drugs publishes
original research, expert reviews and thematic issues in all
core areas of translational and clinical cancer drug research.
The journal publishes pre-clinical and clinical
studies on the development of new anti-cancer agents.
Clinical studies of new reported anti-cancer drugs include
Phase 1 – IV clinical trial studies, their designs,
research methodologies, and analyses. The journal is
essential reading to clinical oncologists, toxicologists,
medicinal chemists, and to pharmacologists.